

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.52457456 |
| 2 | sperm motility (GO:0030317) | 6.35832410 |
| 3 | cell wall macromolecule catabolic process (GO:0016998) | 5.71240306 |
| 4 | cell wall macromolecule metabolic process (GO:0044036) | 5.71240306 |
| 5 | nuclear pore organization (GO:0006999) | 5.45703743 |
| 6 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.18669958 |
| 7 | NADH metabolic process (GO:0006734) | 5.16910533 |
| 8 | carnitine shuttle (GO:0006853) | 5.04451582 |
| 9 | pore complex assembly (GO:0046931) | 4.91993124 |
| 10 | acrosome assembly (GO:0001675) | 4.78599730 |
| 11 | carnitine transmembrane transport (GO:1902603) | 4.77855417 |
| 12 | negative regulation of inclusion body assembly (GO:0090084) | 4.71270139 |
| 13 | acrosome reaction (GO:0007340) | 4.71174678 |
| 14 | mitotic sister chromatid cohesion (GO:0007064) | 4.68389784 |
| 15 | amino-acid betaine transport (GO:0015838) | 4.65843180 |
| 16 | carnitine transport (GO:0015879) | 4.65843180 |
| 17 | biotin metabolic process (GO:0006768) | 4.64244189 |
| 18 | spermatid development (GO:0007286) | 4.58514078 |
| 19 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.54894310 |
| 20 | sperm-egg recognition (GO:0035036) | 4.52841277 |
| 21 | fatty acid transmembrane transport (GO:1902001) | 4.45059720 |
| 22 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.36961077 |
| 23 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.34288460 |
| 24 | mitotic chromosome condensation (GO:0007076) | 4.32483385 |
| 25 | plasma membrane fusion (GO:0045026) | 4.31313121 |
| 26 | multicellular organism reproduction (GO:0032504) | 4.30134284 |
| 27 | triglyceride biosynthetic process (GO:0019432) | 4.04909069 |
| 28 | cell-cell recognition (GO:0009988) | 4.03351389 |
| 29 | tricarboxylic acid cycle (GO:0006099) | 4.02968582 |
| 30 | regulation of centriole replication (GO:0046599) | 4.01249542 |
| 31 | fructose metabolic process (GO:0006000) | 4.00637081 |
| 32 | reproduction (GO:0000003) | 3.99791950 |
| 33 | binding of sperm to zona pellucida (GO:0007339) | 3.98826678 |
| 34 | sperm capacitation (GO:0048240) | 3.94234887 |
| 35 | protein localization to endosome (GO:0036010) | 3.91463946 |
| 36 | DNA unwinding involved in DNA replication (GO:0006268) | 3.90016419 |
| 37 | neutral lipid biosynthetic process (GO:0046460) | 3.86421430 |
| 38 | acylglycerol biosynthetic process (GO:0046463) | 3.86421430 |
| 39 | epithelial cilium movement (GO:0003351) | 3.83800878 |
| 40 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.79073722 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.78587668 |
| 42 | calcium ion-dependent exocytosis (GO:0017156) | 3.70311920 |
| 43 | regulation of inclusion body assembly (GO:0090083) | 3.66719763 |
| 44 | regulation of cilium movement (GO:0003352) | 3.66329967 |
| 45 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.65715553 |
| 46 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.62598467 |
| 47 | regulation of sequestering of triglyceride (GO:0010889) | 3.61070147 |
| 48 | axonemal dynein complex assembly (GO:0070286) | 3.59430117 |
| 49 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.58398453 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 3.56986931 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 3.56986931 |
| 52 | mitotic sister chromatid segregation (GO:0000070) | 3.56071826 |
| 53 | synaptonemal complex assembly (GO:0007130) | 3.53333901 |
| 54 | synaptonemal complex organization (GO:0070193) | 3.46185813 |
| 55 | hemidesmosome assembly (GO:0031581) | 3.44835707 |
| 56 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.40201922 |
| 57 | cellular protein complex localization (GO:0034629) | 3.39135119 |
| 58 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.38013168 |
| 59 | sister chromatid segregation (GO:0000819) | 3.35423915 |
| 60 | pantothenate metabolic process (GO:0015939) | 3.32692731 |
| 61 | desmosome organization (GO:0002934) | 3.31076986 |
| 62 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.30409733 |
| 63 | quaternary ammonium group transport (GO:0015697) | 3.29763796 |
| 64 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.28105537 |
| 65 | acyl-CoA biosynthetic process (GO:0071616) | 3.26631762 |
| 66 | thioester biosynthetic process (GO:0035384) | 3.26631762 |
| 67 | organic cation transport (GO:0015695) | 3.25631489 |
| 68 | intestinal absorption (GO:0050892) | 3.25125944 |
| 69 | COPI coating of Golgi vesicle (GO:0048205) | 3.23424380 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.23424380 |
| 71 | positive regulation of glycolytic process (GO:0045821) | 3.23065673 |
| 72 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.20064091 |
| 73 | alanine transport (GO:0032328) | 3.16983674 |
| 74 | epithelial cell-cell adhesion (GO:0090136) | 3.13436133 |
| 75 | protein complex localization (GO:0031503) | 3.10949298 |
| 76 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09793752 |
| 77 | glycine transport (GO:0015816) | 3.09540500 |
| 78 | proline transport (GO:0015824) | 3.09314241 |
| 79 | metaphase plate congression (GO:0051310) | 3.08892881 |
| 80 | protein localization to chromosome, centromeric region (GO:0071459) | 3.08608401 |
| 81 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.07897659 |
| 82 | vitamin transmembrane transport (GO:0035461) | 3.06953377 |
| 83 | establishment of chromosome localization (GO:0051303) | 3.06622189 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.04892517 |
| 85 | cell adhesion mediated by integrin (GO:0033627) | 3.03933978 |
| 86 | chaperone-mediated protein complex assembly (GO:0051131) | 3.00989652 |
| 87 | mitotic metaphase plate congression (GO:0007080) | 2.98794405 |
| 88 | purine nucleobase biosynthetic process (GO:0009113) | 2.96231838 |
| 89 | * alditol metabolic process (GO:0019400) | 2.96168255 |
| 90 | low-density lipoprotein particle clearance (GO:0034383) | 2.94610604 |
| 91 | sexual reproduction (GO:0019953) | 2.93593784 |
| 92 | intracellular lipid transport (GO:0032365) | 2.92802693 |
| 93 | regulation of sulfur metabolic process (GO:0042762) | 2.91930930 |
| 94 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.91086965 |
| 95 | mammary gland epithelial cell proliferation (GO:0033598) | 2.90983909 |
| 96 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.90308505 |
| 97 | protein localization to kinetochore (GO:0034501) | 2.87948533 |
| 98 | NLS-bearing protein import into nucleus (GO:0006607) | 2.87005488 |
| 99 | fatty acid catabolic process (GO:0009062) | 2.86808952 |
| 100 | hypotonic response (GO:0006971) | 2.86316127 |
| 101 | regulation of triglyceride catabolic process (GO:0010896) | 2.84995387 |
| 102 | cilium movement (GO:0003341) | 2.84637828 |
| 103 | neuronal action potential propagation (GO:0019227) | 2.84089830 |
| 104 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.83768152 |
| 105 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.83691125 |
| 106 | positive regulation of chromosome segregation (GO:0051984) | 2.83329575 |
| 107 | alpha-linolenic acid metabolic process (GO:0036109) | 2.81089507 |
| 108 | motile cilium assembly (GO:0044458) | 2.79403989 |
| 109 | protein targeting to Golgi (GO:0000042) | 2.79099921 |
| 110 | angiotensin maturation (GO:0002003) | 2.76783487 |
| 111 | intestinal epithelial cell development (GO:0060576) | 2.76197985 |
| 112 | negative regulation of DNA repair (GO:0045738) | 2.74480133 |
| 113 | modified amino acid transport (GO:0072337) | 2.73092777 |
| 114 | regulation of microtubule-based movement (GO:0060632) | 2.73038839 |
| 115 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.72247126 |
| 116 | hippo signaling (GO:0035329) | 2.72236581 |
| 117 | phosphatidic acid metabolic process (GO:0046473) | 2.72121390 |
| 118 | phosphatidic acid biosynthetic process (GO:0006654) | 2.72121390 |
| 119 | mitotic spindle organization (GO:0007052) | 2.71888308 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 2.70205428 |
| 121 | regulation of early endosome to late endosome transport (GO:2000641) | 2.70175872 |
| 122 | chromosome condensation (GO:0030261) | 2.66717035 |
| 123 | paraxial mesoderm development (GO:0048339) | 2.66017688 |
| 124 | glycerol ether metabolic process (GO:0006662) | 2.66012637 |
| 125 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.65885257 |
| 126 | fatty acid oxidation (GO:0019395) | 2.65358192 |
| 127 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.65180557 |
| 128 | regulation of sister chromatid cohesion (GO:0007063) | 2.64881967 |
| 129 | lipid oxidation (GO:0034440) | 2.64787313 |
| 130 | membrane disassembly (GO:0030397) | 2.64102119 |
| 131 | nuclear envelope disassembly (GO:0051081) | 2.64102119 |
| 132 | neutral lipid catabolic process (GO:0046461) | 2.63294851 |
| 133 | acylglycerol catabolic process (GO:0046464) | 2.63294851 |
| 134 | positive regulation of protein autophosphorylation (GO:0031954) | 2.62730121 |
| 135 | regulation of fatty acid oxidation (GO:0046320) | 2.61970826 |
| 136 | C4-dicarboxylate transport (GO:0015740) | 2.61620710 |
| 137 | L-amino acid import (GO:0043092) | 2.60543498 |
| 138 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.59619897 |
| 139 | mitotic nuclear envelope disassembly (GO:0007077) | 2.59173105 |
| 140 | cell-substrate junction assembly (GO:0007044) | 2.58478752 |
| 141 | acetyl-CoA metabolic process (GO:0006084) | 2.57270528 |
| 142 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.57145371 |
| 143 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.56712259 |
| 144 | single fertilization (GO:0007338) | 2.56689387 |
| 145 | establishment of protein localization to Golgi (GO:0072600) | 2.56592915 |
| 146 | labyrinthine layer development (GO:0060711) | 2.56475679 |
| 147 | folic acid transport (GO:0015884) | 2.55923661 |
| 148 | amino acid transmembrane transport (GO:0003333) | 2.55621230 |
| 149 | regulation of protein localization to plasma membrane (GO:1903076) | 2.55572206 |
| 150 | * glycerol metabolic process (GO:0006071) | 2.54560386 |
| 151 | triglyceride catabolic process (GO:0019433) | 2.53865932 |
| 152 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.53527867 |
| 153 | cellular potassium ion homeostasis (GO:0030007) | 2.53402167 |
| 154 | spermatogenesis (GO:0007283) | 2.53024004 |
| 155 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.51607576 |
| 156 | mitotic G2/M transition checkpoint (GO:0044818) | 2.51392623 |
| 157 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51342941 |
| 158 | regulation of RIG-I signaling pathway (GO:0039535) | 2.50549421 |
| 159 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.48622562 |
| 160 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.48436677 |
| 161 | regulation of mitotic spindle organization (GO:0060236) | 2.48265073 |
| 162 | keratinocyte proliferation (GO:0043616) | 2.47769316 |
| 163 | protein export from nucleus (GO:0006611) | 2.47507989 |
| 164 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.47372473 |
| 165 | establishment of integrated proviral latency (GO:0075713) | 2.46299298 |
| 166 | positive regulation of macroautophagy (GO:0016239) | 2.45066778 |
| 167 | notochord development (GO:0030903) | 2.44710527 |
| 168 | regulation of centrosome duplication (GO:0010824) | 2.44156917 |
| 169 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.43167362 |
| 170 | ribosome assembly (GO:0042255) | 2.42942447 |
| 171 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.42848576 |
| 172 | mRNA transcription (GO:0009299) | 2.41482740 |
| 173 | regulation of glomerular filtration (GO:0003093) | 2.40644276 |
| 174 | activation of Rac GTPase activity (GO:0032863) | 2.40634636 |
| 175 | regulation of centrosome cycle (GO:0046605) | 2.40116815 |
| 176 | vesicle coating (GO:0006901) | 2.39677543 |
| 177 | iron ion import (GO:0097286) | 2.39477460 |
| 178 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.38268531 |
| 179 | regulation of Rac protein signal transduction (GO:0035020) | 2.37850233 |
| 180 | DNA duplex unwinding (GO:0032508) | 2.37541766 |
| 181 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37412896 |
| 182 | COPII vesicle coating (GO:0048208) | 2.37133822 |
| 183 | glycosphingolipid catabolic process (GO:0046479) | 2.36615569 |
| 184 | DNA packaging (GO:0006323) | 2.35650931 |
| 185 | DNA strand elongation (GO:0022616) | 2.35470944 |
| 186 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.33201078 |
| 187 | positive regulation of cytokinesis (GO:0032467) | 2.32656054 |
| 188 | cell-cell junction assembly (GO:0007043) | 2.30399371 |
| 189 | osteoclast differentiation (GO:0030316) | 2.29957219 |
| 190 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.29379942 |
| 191 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.28644415 |
| 192 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.28644415 |
| 193 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.28644415 |
| 194 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.26746772 |
| 195 | regulation of keratinocyte differentiation (GO:0045616) | 2.26288597 |
| 196 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.25717706 |
| 197 | regulation of chromosome segregation (GO:0051983) | 2.24263522 |
| 198 | peptidyl-threonine modification (GO:0018210) | 2.23588477 |
| 199 | non-recombinational repair (GO:0000726) | 2.22625949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.26588728 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 5.26140199 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.72571097 |
| 4 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.05829106 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.46370033 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.32159283 |
| 7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.17670358 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.15096325 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.07848389 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05926773 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.92721790 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86637783 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.78154957 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.59375377 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.58772025 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.52972551 |
| 17 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.50694176 |
| 18 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.35414480 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34817642 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25936665 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.24666871 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23319814 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.18334904 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11151696 |
| 25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.04231023 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03789509 |
| 27 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.02961908 |
| 28 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.02961908 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96718643 |
| 30 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.94513282 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91518552 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91190980 |
| 33 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.90417246 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89725005 |
| 35 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.88350337 |
| 36 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83951893 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82458389 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.81028893 |
| 39 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.79849067 |
| 40 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.75855789 |
| 41 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.74772498 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.74010292 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72343931 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72092831 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72023534 |
| 46 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70949530 |
| 47 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.69452292 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.64267675 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62579580 |
| 50 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.59872157 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58116473 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57602842 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.56321070 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56308094 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54330000 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49446838 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48361295 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47752635 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46980613 |
| 60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.45712031 |
| 61 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.44220894 |
| 62 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.42672172 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40832377 |
| 64 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.40250935 |
| 65 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.38962523 |
| 66 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38962523 |
| 67 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38827699 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38287837 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38211373 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38211373 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37206650 |
| 72 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.32848243 |
| 73 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.31838269 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30941538 |
| 75 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.30592527 |
| 76 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30313043 |
| 77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29543079 |
| 78 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29293755 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26665631 |
| 80 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.24180018 |
| 81 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.23672377 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23123583 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.22928125 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22900194 |
| 85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22386350 |
| 86 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22022512 |
| 87 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.21860634 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21467360 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19606304 |
| 90 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18977703 |
| 91 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17730394 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17210496 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15844665 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15718706 |
| 95 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15042911 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15035604 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14467000 |
| 98 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13726583 |
| 99 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.12823201 |
| 100 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12264503 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11420997 |
| 102 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.10974249 |
| 103 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10661319 |
| 104 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10648472 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10224983 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09342046 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08744600 |
| 108 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07205345 |
| 109 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.07159109 |
| 110 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06652972 |
| 111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06563492 |
| 112 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06510869 |
| 113 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 1.06417725 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05981860 |
| 115 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.05800729 |
| 116 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05050639 |
| 117 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.04011121 |
| 118 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03988534 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.02992846 |
| 120 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02973158 |
| 121 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02180965 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01464146 |
| 123 | FUS_26573619_Chip-Seq_HEK293_Human | 1.00397852 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00052001 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00047968 |
| 126 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98821194 |
| 127 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98817750 |
| 128 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98383587 |
| 129 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98142437 |
| 130 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97854370 |
| 131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97165560 |
| 132 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97021071 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96707752 |
| 134 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96579265 |
| 135 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96370723 |
| 136 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96306088 |
| 137 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95799528 |
| 138 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94530497 |
| 139 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94321159 |
| 140 | * CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93990427 |
| 141 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93629789 |
| 142 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92967797 |
| 143 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92695218 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92482532 |
| 145 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92327120 |
| 146 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91953991 |
| 147 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.91909055 |
| 148 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91690514 |
| 149 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91589025 |
| 150 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91036231 |
| 151 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90346201 |
| 152 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89207229 |
| 153 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.88786118 |
| 154 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88368858 |
| 155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87659586 |
| 156 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87445745 |
| 157 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87213784 |
| 158 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87002204 |
| 159 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86478096 |
| 160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86320971 |
| 161 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86320971 |
| 162 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.85763270 |
| 163 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85573037 |
| 164 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84967188 |
| 165 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84792933 |
| 166 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.83847370 |
| 167 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83722187 |
| 168 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.83676092 |
| 169 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.83481414 |
| 170 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83455119 |
| 171 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83402177 |
| 172 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83382527 |
| 173 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.82184283 |
| 174 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81973632 |
| 175 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81653137 |
| 176 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.81577679 |
| 177 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81267896 |
| 178 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.81034193 |
| 179 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80986369 |
| 180 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.80876157 |
| 181 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.80868125 |
| 182 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80862124 |
| 183 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80603063 |
| 184 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.79915310 |
| 185 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79681475 |
| 186 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79433120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 5.88132033 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 4.87836028 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.81168611 |
| 4 | MP0005670_abnormal_white_adipose | 3.54816810 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.46304100 |
| 6 | MP0003329_amyloid_beta_deposits | 3.32843988 |
| 7 | MP0004270_analgesia | 3.30441606 |
| 8 | MP0008057_abnormal_DNA_replication | 2.99601900 |
| 9 | MP0010678_abnormal_skin_adnexa | 2.99016447 |
| 10 | MP0004043_abnormal_pH_regulation | 2.78793171 |
| 11 | MP0003941_abnormal_skin_development | 2.67604760 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.54415768 |
| 13 | MP0005360_urolithiasis | 2.50395912 |
| 14 | MP0002796_impaired_skin_barrier | 2.48992596 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.43666762 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.42480389 |
| 17 | MP0003453_abnormal_keratinocyte_physiol | 2.41064396 |
| 18 | MP0000383_abnormal_hair_follicle | 2.37417832 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.34310448 |
| 20 | MP0000013_abnormal_adipose_tissue | 2.30484129 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.24919334 |
| 22 | MP0004130_abnormal_muscle_cell | 2.23568902 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.22018269 |
| 24 | MP0003646_muscle_fatigue | 2.20555292 |
| 25 | MP0005451_abnormal_body_composition | 2.16450917 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 2.10782414 |
| 27 | MP0003880_abnormal_central_pattern | 2.08443750 |
| 28 | MP0010094_abnormal_chromosome_stability | 2.06773139 |
| 29 | MP0000604_amyloidosis | 2.06432406 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 2.06137829 |
| 31 | * MP0005535_abnormal_body_temperature | 2.05058823 |
| 32 | MP0003698_abnormal_male_reproductive | 2.04510763 |
| 33 | MP0010307_abnormal_tumor_latency | 2.01690842 |
| 34 | * MP0002971_abnormal_brown_adipose | 2.01520150 |
| 35 | MP0009840_abnormal_foam_cell | 1.91412089 |
| 36 | * MP0002118_abnormal_lipid_homeostasis | 1.88442816 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.82156260 |
| 38 | MP0005248_abnormal_Harderian_gland | 1.78585531 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.76329027 |
| 40 | MP0005365_abnormal_bile_salt | 1.72382214 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.72056780 |
| 42 | MP0001929_abnormal_gametogenesis | 1.71746508 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.71063545 |
| 44 | MP0008260_abnormal_autophagy | 1.70473407 |
| 45 | MP0003091_abnormal_cell_migration | 1.68758033 |
| 46 | * MP0005332_abnormal_amino_acid | 1.66855085 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.66340253 |
| 48 | MP0009046_muscle_twitch | 1.66004766 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.64536309 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.64421845 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.63829620 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.61375094 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.61207423 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.60706736 |
| 55 | MP0003077_abnormal_cell_cycle | 1.60706370 |
| 56 | MP0005501_abnormal_skin_physiology | 1.57708722 |
| 57 | * MP0002078_abnormal_glucose_homeostasis | 1.57496600 |
| 58 | MP0000003_abnormal_adipose_tissue | 1.53935731 |
| 59 | MP0009745_abnormal_behavioral_response | 1.49026932 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.48854869 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.48246795 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.47254661 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.46086306 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.45831579 |
| 65 | MP0003690_abnormal_glial_cell | 1.43138374 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.42693280 |
| 67 | MP0000579_abnormal_nail_morphology | 1.41931142 |
| 68 | MP0002064_seizures | 1.41780996 |
| 69 | MP0002060_abnormal_skin_morphology | 1.40948815 |
| 70 | MP0000627_abnormal_mammary_gland | 1.39505910 |
| 71 | MP0002876_abnormal_thyroid_physiology | 1.39344038 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.37153006 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.35078419 |
| 74 | MP0001661_extended_life_span | 1.34668934 |
| 75 | MP0008932_abnormal_embryonic_tissue | 1.34119086 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 1.33572726 |
| 77 | MP0001730_embryonic_growth_arrest | 1.32598949 |
| 78 | MP0001849_ear_inflammation | 1.31407136 |
| 79 | MP0009697_abnormal_copulation | 1.29021234 |
| 80 | MP0001486_abnormal_startle_reflex | 1.28335175 |
| 81 | MP0000377_abnormal_hair_follicle | 1.27956732 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 1.27494155 |
| 83 | MP0001765_abnormal_ion_homeostasis | 1.27413408 |
| 84 | MP0002272_abnormal_nervous_system | 1.26433812 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.25739304 |
| 86 | MP0003633_abnormal_nervous_system | 1.24886808 |
| 87 | MP0003828_pulmonary_edema | 1.24646226 |
| 88 | MP0005409_darkened_coat_color | 1.24430862 |
| 89 | MP0000350_abnormal_cell_proliferation | 1.23948212 |
| 90 | MP0005448_abnormal_energy_balance | 1.23524603 |
| 91 | * MP0002161_abnormal_fertility/fecundity | 1.21038967 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 1.19073965 |
| 93 | * MP0002693_abnormal_pancreas_physiology | 1.18313346 |
| 94 | MP0003195_calcinosis | 1.17328127 |
| 95 | MP0004233_abnormal_muscle_weight | 1.14250366 |
| 96 | MP0003693_abnormal_embryo_hatching | 1.13278340 |
| 97 | MP0000427_abnormal_hair_cycle | 1.12290022 |
| 98 | MP0003631_nervous_system_phenotype | 1.11805524 |
| 99 | MP0003448_altered_tumor_morphology | 1.11639178 |
| 100 | MP0002822_catalepsy | 1.11152636 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 1.10533968 |
| 102 | MP0005621_abnormal_cell_physiology | 1.08769742 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 1.07676030 |
| 104 | * MP0000609_abnormal_liver_physiology | 1.07519809 |
| 105 | MP0005408_hypopigmentation | 1.06075089 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 1.05924967 |
| 107 | MP0000747_muscle_weakness | 1.05172759 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04921377 |
| 109 | MP0002896_abnormal_bone_mineralization | 1.04428858 |
| 110 | MP0003879_abnormal_hair_cell | 1.04324742 |
| 111 | * MP0005334_abnormal_fat_pad | 1.04320281 |
| 112 | MP0003890_abnormal_embryonic-extraembry | 1.03511716 |
| 113 | MP0001944_abnormal_pancreas_morphology | 1.02137100 |
| 114 | MP0008872_abnormal_physiological_respon | 1.01880906 |
| 115 | MP0004885_abnormal_endolymph | 0.99992161 |
| 116 | MP0001968_abnormal_touch/_nociception | 0.99527895 |
| 117 | MP0003718_maternal_effect | 0.98756627 |
| 118 | MP0002086_abnormal_extraembryonic_tissu | 0.98711171 |
| 119 | MP0003632_abnormal_nervous_system | 0.97987425 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.97497298 |
| 121 | MP0005380_embryogenesis_phenotype | 0.97408618 |
| 122 | MP0001672_abnormal_embryogenesis/_devel | 0.97408618 |
| 123 | * MP0003953_abnormal_hormone_level | 0.96665119 |
| 124 | MP0001764_abnormal_homeostasis | 0.95632660 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.95563845 |
| 126 | MP0010771_integument_phenotype | 0.95091230 |
| 127 | MP0002733_abnormal_thermal_nociception | 0.94446239 |
| 128 | MP0002009_preneoplasia | 0.93918226 |
| 129 | MP0005023_abnormal_wound_healing | 0.90267937 |
| 130 | MP0008569_lethality_at_weaning | 0.90004956 |
| 131 | MP0000733_abnormal_muscle_development | 0.89751237 |
| 132 | MP0008007_abnormal_cellular_replicative | 0.89529768 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.89399449 |
| 134 | MP0000428_abnormal_craniofacial_morphol | 0.89312154 |
| 135 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89067177 |
| 136 | MP0002090_abnormal_vision | 0.88499131 |
| 137 | MP0006138_congestive_heart_failure | 0.88037440 |
| 138 | MP0001697_abnormal_embryo_size | 0.87414647 |
| 139 | MP0002269_muscular_atrophy | 0.87383468 |
| 140 | MP0005266_abnormal_metabolism | 0.87173436 |
| 141 | MP0008877_abnormal_DNA_methylation | 0.86964605 |
| 142 | MP0009672_abnormal_birth_weight | 0.86589037 |
| 143 | MP0000749_muscle_degeneration | 0.86513181 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.86508303 |
| 145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86358323 |
| 146 | MP0003984_embryonic_growth_retardation | 0.85743993 |
| 147 | MP0005386_behavior/neurological_phenoty | 0.85456656 |
| 148 | MP0004924_abnormal_behavior | 0.85456656 |
| 149 | * MP0005319_abnormal_enzyme/_coenzyme | 0.84286837 |
| 150 | MP0005165_increased_susceptibility_to | 0.83664223 |
| 151 | MP0005384_cellular_phenotype | 0.83329978 |
| 152 | MP0000462_abnormal_digestive_system | 0.82987969 |
| 153 | MP0002088_abnormal_embryonic_growth/wei | 0.82038731 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.81872598 |
| 155 | MP0004036_abnormal_muscle_relaxation | 0.81165651 |
| 156 | * MP0002080_prenatal_lethality | 0.80861737 |
| 157 | MP0002736_abnormal_nociception_after | 0.80532320 |
| 158 | MP0004272_abnormal_basement_membrane | 0.80462508 |
| 159 | MP0005197_abnormal_uvea_morphology | 0.80429024 |
| 160 | MP0003303_peritoneal_inflammation | 0.79907896 |
| 161 | MP0001881_abnormal_mammary_gland | 0.78966894 |
| 162 | * MP0009115_abnormal_fat_cell | 0.78874410 |
| 163 | MP0001191_abnormal_skin_condition | 0.78719308 |
| 164 | MP0004510_myositis | 0.76489395 |
| 165 | MP0000647_abnormal_sebaceous_gland | 0.75512922 |
| 166 | MP0005058_abnormal_lysosome_morphology | 0.75430163 |
| 167 | MP0004808_abnormal_hematopoietic_stem | 0.75224755 |
| 168 | MP0005647_abnormal_sex_gland | 0.74696030 |
| 169 | MP0002332_abnormal_exercise_endurance | 0.74493076 |
| 170 | * MP0005452_abnormal_adipose_tissue | 0.74079562 |
| 171 | MP0002067_abnormal_sensory_capabilities | 0.74072130 |
| 172 | MP0002066_abnormal_motor_capabilities/c | 0.73680764 |
| 173 | MP0003656_abnormal_erythrocyte_physiolo | 0.73575037 |
| 174 | MP0000015_abnormal_ear_pigmentation | 0.73569166 |
| 175 | MP0001851_eye_inflammation | 0.73343848 |
| 176 | MP0005636_abnormal_mineral_homeostasis | 0.72771162 |
| 177 | MP0001145_abnormal_male_reproductive | 0.72241582 |
| 178 | MP0004087_abnormal_muscle_fiber | 0.72209322 |
| 179 | MP0004858_abnormal_nervous_system | 0.72189758 |
| 180 | MP0003075_altered_response_to | 0.72059910 |
| 181 | MP0008004_abnormal_stomach_pH | 0.71757342 |
| 182 | MP0004197_abnormal_fetal_growth/weight/ | 0.70545847 |
| 183 | MP0000358_abnormal_cell_content/ | 0.70162571 |
| 184 | MP0006054_spinal_hemorrhage | 0.69685986 |
| 185 | MP0005464_abnormal_platelet_physiology | 0.68981978 |
| 186 | MP0001299_abnormal_eye_distance/ | 0.68142810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.35356746 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.19556332 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 5.19556332 |
| 4 | Abnormality of glycine metabolism (HP:0010895) | 4.46438624 |
| 5 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.46438624 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.44462805 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.32899225 |
| 8 | Hyperglycinemia (HP:0002154) | 4.24484775 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.01219104 |
| 10 | Papillary thyroid carcinoma (HP:0002895) | 3.91521874 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.86566621 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 3.86566621 |
| 13 | Focal motor seizures (HP:0011153) | 3.75244641 |
| 14 | Myoglobinuria (HP:0002913) | 3.68877106 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.56085012 |
| 16 | Global brain atrophy (HP:0002283) | 3.43841283 |
| 17 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.40480721 |
| 18 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.40480721 |
| 19 | Chromsome breakage (HP:0040012) | 3.35321678 |
| 20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.34036458 |
| 21 | Ankyloglossia (HP:0010296) | 3.29379057 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 3.26564423 |
| 23 | Hyperglycemia (HP:0003074) | 3.23881874 |
| 24 | Neurofibrillary tangles (HP:0002185) | 3.16790082 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.15241894 |
| 26 | Abnormality of oral frenula (HP:0000190) | 3.03091984 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.00631272 |
| 28 | Chronic bronchitis (HP:0004469) | 3.00287375 |
| 29 | Spastic tetraparesis (HP:0001285) | 2.92758747 |
| 30 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.92133926 |
| 31 | Nemaline bodies (HP:0003798) | 2.81821314 |
| 32 | Subacute progressive viral hepatitis (HP:0006572) | 2.81221152 |
| 33 | Exercise-induced myalgia (HP:0003738) | 2.81195792 |
| 34 | Infertility (HP:0000789) | 2.77176696 |
| 35 | Visual hallucinations (HP:0002367) | 2.76659759 |
| 36 | Hypoglycemic seizures (HP:0002173) | 2.74092950 |
| 37 | Progressive external ophthalmoplegia (HP:0000590) | 2.74023939 |
| 38 | Tetraplegia (HP:0002445) | 2.73879604 |
| 39 | Short nail (HP:0001799) | 2.70878248 |
| 40 | Volvulus (HP:0002580) | 2.66195876 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 2.65709390 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.65709390 |
| 43 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.63003124 |
| 44 | Leiomyosarcoma (HP:0100243) | 2.61818006 |
| 45 | Uterine leiomyosarcoma (HP:0002891) | 2.61818006 |
| 46 | Thyroid carcinoma (HP:0002890) | 2.61783318 |
| 47 | Ketoacidosis (HP:0001993) | 2.61210006 |
| 48 | Bundle branch block (HP:0011710) | 2.58967247 |
| 49 | Absent frontal sinuses (HP:0002688) | 2.57512169 |
| 50 | Muscle fiber inclusion bodies (HP:0100299) | 2.53335828 |
| 51 | Gout (HP:0001997) | 2.52538915 |
| 52 | Rhinitis (HP:0012384) | 2.51960580 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.51349988 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51293828 |
| 55 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.50151436 |
| 56 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.48538030 |
| 57 | Deep philtrum (HP:0002002) | 2.48378066 |
| 58 | Ketosis (HP:0001946) | 2.45533724 |
| 59 | Autoamputation (HP:0001218) | 2.44248645 |
| 60 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.43983263 |
| 61 | Gastrointestinal carcinoma (HP:0002672) | 2.43983263 |
| 62 | Difficulty running (HP:0009046) | 2.42192017 |
| 63 | Male infertility (HP:0003251) | 2.42179171 |
| 64 | Hyperammonemia (HP:0001987) | 2.40683879 |
| 65 | Abnormal auditory evoked potentials (HP:0006958) | 2.39213078 |
| 66 | Urethral obstruction (HP:0000796) | 2.38439687 |
| 67 | Microglossia (HP:0000171) | 2.37792015 |
| 68 | Tetraparesis (HP:0002273) | 2.37290299 |
| 69 | Delusions (HP:0000746) | 2.36830424 |
| 70 | Glucose intolerance (HP:0000833) | 2.36244895 |
| 71 | Insulin resistance (HP:0000855) | 2.33868614 |
| 72 | Bladder neoplasm (HP:0009725) | 2.33712582 |
| 73 | Bladder carcinoma (HP:0002862) | 2.33712582 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.31715663 |
| 75 | Hyperventilation (HP:0002883) | 2.30032179 |
| 76 | Hypobetalipoproteinemia (HP:0003563) | 2.29192726 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.28354049 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.26730546 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.26730546 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.26430738 |
| 81 | Focal seizures (HP:0007359) | 2.25548803 |
| 82 | Methylmalonic aciduria (HP:0012120) | 2.25521526 |
| 83 | Confusion (HP:0001289) | 2.23737547 |
| 84 | Athetosis (HP:0002305) | 2.23361374 |
| 85 | Curly hair (HP:0002212) | 2.22510994 |
| 86 | Lower limb amyotrophy (HP:0007210) | 2.18966789 |
| 87 | Vertebral arch anomaly (HP:0008438) | 2.18558150 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18466169 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18466169 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18466169 |
| 91 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.18259204 |
| 92 | Dialeptic seizures (HP:0011146) | 2.17778972 |
| 93 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17400761 |
| 94 | Hemiparesis (HP:0001269) | 2.16206691 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 2.16026980 |
| 96 | Abnormal ciliary motility (HP:0012262) | 2.15660510 |
| 97 | Selective tooth agenesis (HP:0001592) | 2.14873858 |
| 98 | Scanning speech (HP:0002168) | 2.14801318 |
| 99 | Impulsivity (HP:0100710) | 2.14413186 |
| 100 | Irritability (HP:0000737) | 2.13998358 |
| 101 | Rhabdomyosarcoma (HP:0002859) | 2.12146043 |
| 102 | Oligomenorrhea (HP:0000876) | 2.11139477 |
| 103 | Abnormal glucose tolerance (HP:0001952) | 2.10900944 |
| 104 | Insidious onset (HP:0003587) | 2.10725822 |
| 105 | Termporal pattern (HP:0011008) | 2.10725822 |
| 106 | Medulloblastoma (HP:0002885) | 2.10089632 |
| 107 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09983132 |
| 108 | Hypolipoproteinemia (HP:0010981) | 2.09671994 |
| 109 | Syringomyelia (HP:0003396) | 2.09018534 |
| 110 | Spinal cord lesions (HP:0100561) | 2.09018534 |
| 111 | Exercise-induced muscle cramps (HP:0003710) | 2.08281978 |
| 112 | Absence seizures (HP:0002121) | 2.06138749 |
| 113 | Periodontitis (HP:0000704) | 2.04301270 |
| 114 | Symptomatic seizures (HP:0011145) | 2.04039558 |
| 115 | Uterine neoplasm (HP:0010784) | 2.03883975 |
| 116 | Biliary tract neoplasm (HP:0100574) | 2.01938867 |
| 117 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.01631762 |
| 118 | Xanthomatosis (HP:0000991) | 2.00955524 |
| 119 | Micronodular cirrhosis (HP:0001413) | 1.98846764 |
| 120 | Lethargy (HP:0001254) | 1.97391212 |
| 121 | Increased purine levels (HP:0004368) | 1.96249279 |
| 122 | Hyperuricemia (HP:0002149) | 1.96249279 |
| 123 | Abnormality of the lower motor neuron (HP:0002366) | 1.96202723 |
| 124 | Dysautonomia (HP:0002459) | 1.96083868 |
| 125 | Limb hypertonia (HP:0002509) | 1.95839293 |
| 126 | Restlessness (HP:0000711) | 1.95219095 |
| 127 | Relative macrocephaly (HP:0004482) | 1.94714574 |
| 128 | Difficulty climbing stairs (HP:0003551) | 1.93307260 |
| 129 | Hyperkalemia (HP:0002153) | 1.93297200 |
| 130 | Abnormality of chromosome stability (HP:0003220) | 1.92985593 |
| 131 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92921546 |
| 132 | Neoplasm of the small intestine (HP:0100833) | 1.92820027 |
| 133 | Orthostatic hypotension (HP:0001278) | 1.92682497 |
| 134 | Generalized tonic-clonic seizures (HP:0002069) | 1.90736072 |
| 135 | Dysmetric saccades (HP:0000641) | 1.90376018 |
| 136 | Epileptic encephalopathy (HP:0200134) | 1.90145592 |
| 137 | Impaired smooth pursuit (HP:0007772) | 1.89398708 |
| 138 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89057004 |
| 139 | Abnormality of alanine metabolism (HP:0010916) | 1.88648711 |
| 140 | Hyperalaninemia (HP:0003348) | 1.88648711 |
| 141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.88648711 |
| 142 | Atonic seizures (HP:0010819) | 1.88484522 |
| 143 | Neurodegeneration (HP:0002180) | 1.88444234 |
| 144 | Abnormal platelet volume (HP:0011876) | 1.86514579 |
| 145 | Renal cell carcinoma (HP:0005584) | 1.85569325 |
| 146 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84925654 |
| 147 | Abnormality of purine metabolism (HP:0004352) | 1.84561482 |
| 148 | Resting tremor (HP:0002322) | 1.84310044 |
| 149 | Myocardial infarction (HP:0001658) | 1.83442920 |
| 150 | Increased nuchal translucency (HP:0010880) | 1.82798845 |
| 151 | Ileus (HP:0002595) | 1.82746782 |
| 152 | Pheochromocytoma (HP:0002666) | 1.82575777 |
| 153 | Abnormal social behavior (HP:0012433) | 1.81554952 |
| 154 | Impaired social interactions (HP:0000735) | 1.81554952 |
| 155 | Hypoalphalipoproteinemia (HP:0003233) | 1.79822890 |
| 156 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78802692 |
| 157 | Abnormality of the corticospinal tract (HP:0002492) | 1.78607291 |
| 158 | Increased connective tissue (HP:0009025) | 1.78143948 |
| 159 | Progressive sensorineural hearing impairment (HP:0000408) | 1.77768415 |
| 160 | Generalized aminoaciduria (HP:0002909) | 1.77199075 |
| 161 | Acute myeloid leukemia (HP:0004808) | 1.76934782 |
| 162 | Myopathic facies (HP:0002058) | 1.76521687 |
| 163 | Supranuclear gaze palsy (HP:0000605) | 1.76473812 |
| 164 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.76303762 |
| 165 | Subaortic stenosis (HP:0001682) | 1.76303762 |
| 166 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.76253936 |
| 167 | Deviation of the thumb (HP:0009603) | 1.76136236 |
| 168 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.74451360 |
| 169 | Thick nail (HP:0001805) | 1.74078250 |
| 170 | Apathy (HP:0000741) | 1.72669945 |
| 171 | Abnormality of the salivary glands (HP:0010286) | 1.72450994 |
| 172 | Progressive cerebellar ataxia (HP:0002073) | 1.72388562 |
| 173 | Abnormality of vitamin B metabolism (HP:0004340) | 1.71702607 |
| 174 | Glioma (HP:0009733) | 1.71548107 |
| 175 | Abnormality of vision evoked potentials (HP:0000649) | 1.71297711 |
| 176 | Astrocytoma (HP:0009592) | 1.70935593 |
| 177 | Abnormality of the astrocytes (HP:0100707) | 1.70935593 |
| 178 | Abnormality of the preputium (HP:0100587) | 1.70510448 |
| 179 | Flat acetabular roof (HP:0003180) | 1.69419425 |
| 180 | Freckling (HP:0001480) | 1.67019416 |
| 181 | Neoplasm of the thyroid gland (HP:0100031) | 1.66540027 |
| 182 | Aplasia cutis congenita (HP:0001057) | 1.66091178 |
| 183 | Pelvic girdle muscle weakness (HP:0003749) | 1.65800272 |
| 184 | Progressive hearing impairment (HP:0001730) | 1.64733555 |
| 185 | Large earlobe (HP:0009748) | 1.62960505 |
| 186 | Milia (HP:0001056) | 1.62743191 |
| 187 | Bone pain (HP:0002653) | 1.61240097 |
| 188 | Natal tooth (HP:0000695) | 1.60027438 |
| 189 | Axonal loss (HP:0003447) | 1.58558297 |
| 190 | Hyperacusis (HP:0010780) | 1.58145261 |
| 191 | Decreased motor nerve conduction velocity (HP:0003431) | 1.57557241 |
| 192 | Malnutrition (HP:0004395) | 1.57313578 |
| 193 | Proximal placement of thumb (HP:0009623) | 1.57166039 |
| 194 | Cystic hygroma (HP:0000476) | 1.55773071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 6.51101794 |
| 2 | PDK3 | 6.51101794 |
| 3 | PDK2 | 4.55310521 |
| 4 | PNCK | 3.63950753 |
| 5 | PRKD3 | 3.53787537 |
| 6 | SCYL2 | 3.22492905 |
| 7 | EPHA4 | 2.99315774 |
| 8 | MST4 | 2.46562176 |
| 9 | NTRK3 | 2.44827366 |
| 10 | RIPK4 | 2.41384128 |
| 11 | MET | 2.39772249 |
| 12 | AKT3 | 2.33962059 |
| 13 | BCKDK | 2.15421285 |
| 14 | MAP3K9 | 2.01386974 |
| 15 | MAP3K12 | 1.97094394 |
| 16 | PLK4 | 1.92123819 |
| 17 | TTN | 1.76951055 |
| 18 | MAP3K2 | 1.55290720 |
| 19 | KSR2 | 1.54365855 |
| 20 | YES1 | 1.54194511 |
| 21 | EPHA2 | 1.53629929 |
| 22 | TRIM28 | 1.53568843 |
| 23 | FRK | 1.53292128 |
| 24 | WEE1 | 1.49944851 |
| 25 | STK24 | 1.47572042 |
| 26 | PDGFRA | 1.44786109 |
| 27 | INSRR | 1.44201437 |
| 28 | TESK1 | 1.44162658 |
| 29 | CAMK1G | 1.43040997 |
| 30 | EIF2AK1 | 1.40471681 |
| 31 | ARAF | 1.39417467 |
| 32 | CDC7 | 1.38035292 |
| 33 | PAK4 | 1.37864511 |
| 34 | ERBB4 | 1.36456594 |
| 35 | PDPK1 | 1.35021625 |
| 36 | NME1 | 1.33910756 |
| 37 | PDK1 | 1.27582804 |
| 38 | STK38L | 1.21009740 |
| 39 | NEK1 | 1.19237802 |
| 40 | ERBB3 | 1.18043321 |
| 41 | STK3 | 1.17700874 |
| 42 | IRAK2 | 1.15468523 |
| 43 | BUB1 | 1.15233819 |
| 44 | CAMK1D | 1.14780159 |
| 45 | NEK9 | 1.14157725 |
| 46 | STK38 | 1.11774736 |
| 47 | MINK1 | 1.11082175 |
| 48 | TRPM7 | 1.10886222 |
| 49 | EEF2K | 1.06677947 |
| 50 | TSSK6 | 1.05560128 |
| 51 | SIK3 | 1.03091526 |
| 52 | PTK2B | 1.00550665 |
| 53 | ACVR1B | 0.99076912 |
| 54 | LATS1 | 0.96354094 |
| 55 | STK39 | 0.93683658 |
| 56 | MAP2K4 | 0.93474647 |
| 57 | ALK | 0.93105924 |
| 58 | OBSCN | 0.91251914 |
| 59 | NTRK1 | 0.90932546 |
| 60 | PRKCG | 0.89800024 |
| 61 | PAK6 | 0.89795613 |
| 62 | IRAK3 | 0.89261339 |
| 63 | BRD4 | 0.89082345 |
| 64 | STK10 | 0.88911410 |
| 65 | TTK | 0.87666080 |
| 66 | PASK | 0.86356058 |
| 67 | RIPK1 | 0.85636285 |
| 68 | CDK6 | 0.84303167 |
| 69 | DAPK2 | 0.83211105 |
| 70 | LMTK2 | 0.83000194 |
| 71 | BMX | 0.82520869 |
| 72 | MAP3K4 | 0.82427685 |
| 73 | MELK | 0.82392176 |
| 74 | NME2 | 0.82287818 |
| 75 | MAP3K3 | 0.82102200 |
| 76 | ROCK2 | 0.79333952 |
| 77 | RPS6KB2 | 0.77771512 |
| 78 | MARK1 | 0.76772732 |
| 79 | PINK1 | 0.76617599 |
| 80 | PDGFRB | 0.76370213 |
| 81 | PTK2 | 0.76343394 |
| 82 | CAMKK1 | 0.75490388 |
| 83 | CDK12 | 0.75225295 |
| 84 | MAP3K13 | 0.74849014 |
| 85 | MAP3K8 | 0.71671497 |
| 86 | PLK2 | 0.68634404 |
| 87 | DMPK | 0.66109344 |
| 88 | BRSK1 | 0.65746735 |
| 89 | KSR1 | 0.64071705 |
| 90 | PLK3 | 0.63107669 |
| 91 | MAP2K1 | 0.63101305 |
| 92 | CDK5 | 0.60953900 |
| 93 | BRSK2 | 0.60041330 |
| 94 | WNK4 | 0.58243293 |
| 95 | MAPKAPK3 | 0.57302937 |
| 96 | CAMK2B | 0.56349079 |
| 97 | BMPR2 | 0.54035422 |
| 98 | ICK | 0.53635580 |
| 99 | MAP3K1 | 0.52349012 |
| 100 | CAMKK2 | 0.51365318 |
| 101 | TRIB3 | 0.51297300 |
| 102 | MAP3K14 | 0.51012938 |
| 103 | SRPK1 | 0.50853948 |
| 104 | FGFR1 | 0.50176736 |
| 105 | RAF1 | 0.49722072 |
| 106 | CCNB1 | 0.49610665 |
| 107 | MKNK1 | 0.49284408 |
| 108 | PRKAA1 | 0.49195560 |
| 109 | BRAF | 0.48124363 |
| 110 | AKT2 | 0.46513643 |
| 111 | PBK | 0.44053601 |
| 112 | AURKB | 0.42033412 |
| 113 | FGR | 0.42004161 |
| 114 | PRKAA2 | 0.41648995 |
| 115 | CAMK2A | 0.40950771 |
| 116 | PIK3CG | 0.40533641 |
| 117 | PKN2 | 0.40429141 |
| 118 | OXSR1 | 0.39913824 |
| 119 | CDK14 | 0.39753751 |
| 120 | TAF1 | 0.38564359 |
| 121 | MST1R | 0.38181411 |
| 122 | MOS | 0.38138245 |
| 123 | PRKG2 | 0.38111913 |
| 124 | PRKACG | 0.36437328 |
| 125 | RPS6KA4 | 0.36412702 |
| 126 | FER | 0.36332807 |
| 127 | PHKG2 | 0.35789987 |
| 128 | PHKG1 | 0.35789987 |
| 129 | CAMK2G | 0.35679792 |
| 130 | MTOR | 0.35583862 |
| 131 | RPS6KA3 | 0.35457433 |
| 132 | EIF2AK2 | 0.35409709 |
| 133 | GRK5 | 0.35240209 |
| 134 | TYK2 | 0.35099041 |
| 135 | NEK6 | 0.34283636 |
| 136 | DAPK1 | 0.34202579 |
| 137 | CAMK2D | 0.33554326 |
| 138 | WNK3 | 0.33299638 |
| 139 | CSNK1E | 0.33228791 |
| 140 | NEK2 | 0.33162983 |
| 141 | PAK2 | 0.31793696 |
| 142 | RPS6KB1 | 0.31766228 |
| 143 | MAP2K7 | 0.31674016 |
| 144 | CDK15 | 0.31439952 |
| 145 | MAP2K6 | 0.31189756 |
| 146 | CSNK1A1 | 0.30731766 |
| 147 | PRKCZ | 0.30597831 |
| 148 | STK11 | 0.30523097 |
| 149 | JAK1 | 0.30426531 |
| 150 | MAPK10 | 0.30419420 |
| 151 | CHEK2 | 0.29551301 |
| 152 | TAOK2 | 0.29456115 |
| 153 | CDK7 | 0.29381904 |
| 154 | CHEK1 | 0.28239954 |
| 155 | CDK18 | 0.27731819 |
| 156 | EIF2AK3 | 0.27008206 |
| 157 | MAP3K5 | 0.26214635 |
| 158 | BCR | 0.25884127 |
| 159 | LATS2 | 0.24675664 |
| 160 | PRKCE | 0.24615730 |
| 161 | SGK1 | 0.24512631 |
| 162 | PLK1 | 0.23635237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.52112769 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.29572923 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.23378151 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.01641099 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75747286 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.71519162 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52675320 |
| 8 | Adherens junction_Homo sapiens_hsa04520 | 2.40455634 |
| 9 | Thyroid cancer_Homo sapiens_hsa05216 | 2.33692984 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.25229725 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.16185147 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.13660002 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97028185 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94725810 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.93045265 |
| 16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.88893575 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.85000793 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.81879495 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.80867991 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80251720 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.79536805 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74357423 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.70339084 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.70039939 |
| 25 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.69294946 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.63057484 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61710187 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.61619049 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.61204969 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.61203533 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59949851 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.59896383 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.54233705 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.53303837 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.52007446 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.45692987 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45542510 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.44650667 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41546157 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40812519 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.39623442 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.39476810 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.38853678 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.38674152 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36732581 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 1.33567188 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.32307575 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32007671 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28435867 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.27397822 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.23609646 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23048915 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19275753 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 1.18880757 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18177343 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 1.13081636 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.12289877 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 1.11387754 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11140004 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08857449 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.08679466 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.07866124 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07209579 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03376360 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.02521848 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01491372 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 1.01469452 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01376653 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00953485 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00845511 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.99539216 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.99324652 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99154839 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98842761 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98268646 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96948382 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.96884232 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96315198 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95447035 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95383493 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95136666 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94227355 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93856518 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92675387 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.92084663 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.91048890 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90338564 |
| 88 | RNA transport_Homo sapiens_hsa03013 | 0.89553441 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87093865 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85818952 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84189637 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84071676 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.83514905 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83451868 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82820193 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82788595 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82390541 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82099659 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.80816245 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80592843 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80112236 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79576002 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78032814 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77911297 |
| 105 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.77483845 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76324525 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.75709141 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75184589 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74616965 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.73304203 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72707764 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.72439468 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71392971 |
| 114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.70621237 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70515484 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69992224 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.69843987 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68712063 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68307892 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66454725 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65703766 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.65413228 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64949021 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64776733 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64636817 |
| 126 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63118885 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62891719 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62057026 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61692946 |
| 130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60914953 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60165267 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.59780302 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.59398116 |
| 134 | Long-term depression_Homo sapiens_hsa04730 | 0.59365631 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58844512 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58257928 |
| 137 | Taste transduction_Homo sapiens_hsa04742 | 0.57446085 |
| 138 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55771265 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54720933 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54566032 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52995141 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52382092 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52072833 |
| 144 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51747481 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51413841 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.50965821 |
| 147 | Alcoholism_Homo sapiens_hsa05034 | 0.50885387 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50403445 |
| 149 | Morphine addiction_Homo sapiens_hsa05032 | 0.49655557 |
| 150 | Melanoma_Homo sapiens_hsa05218 | 0.49228461 |
| 151 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49135721 |
| 152 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48893081 |
| 153 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47949224 |
| 154 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45667331 |
| 155 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45524098 |
| 156 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43934772 |
| 157 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42284888 |
| 158 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41651844 |
| 159 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40849101 |
| 160 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40809812 |
| 161 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40165347 |
| 162 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38668798 |
| 163 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37782782 |
| 164 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37744075 |
| 165 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36620239 |
| 166 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36572880 |
| 167 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35253992 |
| 168 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34523654 |
| 169 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33672567 |
| 170 | Purine metabolism_Homo sapiens_hsa00230 | 0.32923538 |
| 171 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30731530 |

